VANDA PHARMACEUTICALS INC. Dilutive Share Adjustment
VANDA PHARMACEUTICALS INC. (VNDA) reported Dilutive Share Adjustment of 0 shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment · last filed 2026-02-12
- VANDA PHARMACEUTICALS INC. weighted average number diluted shares outstanding adjustment for the quarter ending 2024-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- VANDA PHARMACEUTICALS INC. weighted average number diluted shares outstanding adjustment for the quarter ending 2024-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- VANDA PHARMACEUTICALS INC. weighted average number diluted shares outstanding adjustment for the quarter ending 2024-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- VANDA PHARMACEUTICALS INC. weighted average number diluted shares outstanding adjustment for the quarter ending 2024-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- VANDA PHARMACEUTICALS INC. weighted average number diluted shares outstanding adjustment for fiscal 2025 was 0.00 shares.
- VANDA PHARMACEUTICALS INC. weighted average number diluted shares outstanding adjustment for fiscal 2024 was 0.00 shares, a 100.00% decline from fiscal 2023.
- VANDA PHARMACEUTICALS INC. weighted average number diluted shares outstanding adjustment for fiscal 2023 was 176.94K shares, a 66.06% decline from fiscal 2022.
- VANDA PHARMACEUTICALS INC. weighted average number diluted shares outstanding adjustment for fiscal 2022 was 521.29K shares, a 62.05% decline from fiscal 2021.
| Period end | Weighted Average Number Diluted Shares Outstanding Adjustment 3 month | Weighted Average Number Diluted Shares Outstanding Adjustment 6 month | Weighted Average Number Diluted Shares Outstanding Adjustment 9 month | Weighted Average Number Diluted Shares Outstanding Adjustment 12 month |
|---|---|---|---|---|
| 2025-12-31 | 0.00 shares 10-K · filed 2026-02-12 | |||
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | 0.00 shares derived: average of 2 quarters · filed 2026-02-12 | 0.00 shares derived: average of 3 quarters · filed 2026-02-12 | 0.00 shares 10-K · filed 2026-02-12 |
| 2024-09-30 | 0.00 shares 10-Q · filed 2024-11-07 | 0.00 shares derived: average of 2 quarters · filed 2024-11-07 | 0.00 shares 10-Q · filed 2024-11-07 | 40.24K shares derived: average of 4 quarters · filed 2026-02-12 |
| 2024-06-30 | 0.00 shares 10-Q · filed 2024-08-01 | 0.00 shares 10-Q · filed 2024-08-01 | 53.66K shares derived: average of 3 quarters · filed 2026-02-12 | 59.32K shares derived: average of 4 quarters · filed 2026-02-12 |
| 2024-03-31 | 0.00 shares 10-Q · filed 2024-05-09 | 80.49K shares derived: average of 2 quarters · filed 2026-02-12 | 79.10K shares derived: average of 3 quarters · filed 2026-02-12 | 79.75K shares derived: average of 4 quarters · filed 2026-02-12 |
| 2023-12-31 | 160.98K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | 118.64K shares derived: average of 2 quarters · filed 2026-02-12 | 106.33K shares derived: average of 3 quarters · filed 2026-02-12 | 176.94K shares 10-K · filed 2026-02-12 |
| 2023-09-30 | 76.31K shares 10-Q · filed 2024-11-07 | 79.01K shares derived: average of 2 quarters · filed 2024-11-07 | 182.26K shares 10-Q · filed 2024-11-07 | 657.99K shares derived: average of 4 quarters · filed 2025-02-14 |
| 2023-06-30 | 81.70K shares 10-Q · filed 2024-08-01 | 235.23K shares 10-Q · filed 2024-08-01 | 851.88K shares derived: average of 3 quarters · filed 2025-02-14 | 737.54K shares derived: average of 4 quarters · filed 2025-02-14 |
| 2023-03-31 | 388.76K shares 10-Q · filed 2024-05-09 | 1.24M shares derived: average of 2 quarters · filed 2025-02-14 | 956.15K shares derived: average of 3 quarters · filed 2025-02-14 | 795.24K shares derived: average of 4 quarters · filed 2025-02-14 |
| 2022-12-31 | 2.09M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | 1.24M shares derived: average of 2 quarters · filed 2025-02-14 | 930.73K shares derived: average of 3 quarters · filed 2025-02-14 | 521.29K shares 10-K · filed 2025-02-14 |
| 2022-09-30 | 394.53K shares 10-Q · filed 2023-11-09 | 353.51K shares derived: average of 2 quarters · filed 2023-11-09 | 0.00 shares 10-Q · filed 2023-11-09 | 537.39K shares derived: average of 4 quarters · filed 2024-02-08 |
| 2022-06-30 | 312.49K shares 10-Q · filed 2023-07-28 | 0.00 shares 10-Q · filed 2023-07-28 | 585.02K shares derived: average of 3 quarters · filed 2024-02-08 | 781.91K shares derived: average of 4 quarters · filed 2024-02-08 |
| 2022-03-31 | 0.00 shares 10-Q · filed 2023-05-03 | 721.28K shares derived: average of 2 quarters · filed 2024-02-08 | 938.38K shares derived: average of 3 quarters · filed 2024-02-08 | 1.03M shares derived: average of 4 quarters · filed 2024-02-08 |
| 2021-12-31 | 1.44M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-08 | 1.41M shares derived: average of 2 quarters · filed 2024-02-08 | 1.38M shares derived: average of 3 quarters · filed 2024-02-08 | 1.37M shares 10-K · filed 2024-02-08 |
| 2021-09-30 | 1.37M shares 10-Q · filed 2022-11-03 | 1.35M shares derived: average of 2 quarters · filed 2022-11-03 | 1.35M shares 10-Q · filed 2022-11-03 | 1.23M shares derived: average of 4 quarters · filed 2023-02-09 |
| 2021-06-30 | 1.32M shares 10-Q · filed 2022-08-04 | 1.34M shares 10-Q · filed 2022-08-04 | 1.18M shares derived: average of 3 quarters · filed 2023-02-09 | 1.02M shares derived: average of 4 quarters · filed 2023-02-09 |
| 2021-03-31 | 1.36M shares 10-Q · filed 2022-05-06 | 1.11M shares derived: average of 2 quarters · filed 2023-02-09 | 922.62K shares derived: average of 3 quarters · filed 2023-02-09 | 836.99K shares derived: average of 4 quarters · filed 2023-02-09 |
| 2020-12-31 | 865.66K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-09 | 704.28K shares derived: average of 2 quarters · filed 2023-02-09 | 662.88K shares derived: average of 3 quarters · filed 2023-02-09 | 763.12K shares 10-K · filed 2023-02-09 |
| 2020-09-30 | 542.90K shares 10-Q · filed 2021-11-04 | 561.50K shares derived: average of 2 quarters · filed 2021-11-04 | 728.94K shares 10-Q · filed 2021-11-04 | 942.71K shares derived: average of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | 580.09K shares 10-Q · filed 2021-07-29 | 821.96K shares 10-Q · filed 2021-07-29 | 1.08M shares derived: average of 3 quarters · filed 2022-02-24 | 1.12M shares derived: average of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | 1.06M shares 10-Q · filed 2021-05-06 | 1.32M shares derived: average of 2 quarters · filed 2022-02-24 | 1.30M shares derived: average of 3 quarters · filed 2022-02-24 | 1.34M shares derived: average of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | 1.58M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | 1.41M shares derived: average of 2 quarters · filed 2022-02-24 | 1.44M shares derived: average of 3 quarters · filed 2022-02-24 | 1.71M shares 10-K · filed 2022-02-24 |
| 2019-09-30 | 1.24M shares 10-Q · filed 2020-10-29 | 1.36M shares derived: average of 2 quarters · filed 2020-10-29 | 1.75M shares 10-Q · filed 2020-10-29 | 1.37M shares derived: average of 4 quarters · filed 2021-02-11 |
| 2019-06-30 | 1.48M shares 10-Q · filed 2020-08-06 | 2.00M shares 10-Q · filed 2020-08-06 | 1.41M shares derived: average of 3 quarters · filed 2021-02-11 | 1.64M shares derived: average of 4 quarters · filed 2021-02-11 |
| 2019-03-31 | 0.00 shares 10-Q · filed 2020-05-07 | 1.38M shares derived: average of 2 quarters · filed 2021-02-11 | 1.69M shares derived: average of 3 quarters · filed 2021-02-11 | 1.71M shares derived: average of 4 quarters · filed 2021-02-11 |
| 2018-12-31 | 2.76M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | 2.54M shares derived: average of 2 quarters · filed 2021-02-11 | 2.28M shares derived: average of 3 quarters · filed 2021-02-11 | 2.19M shares 10-K · filed 2021-02-11 |
| 2018-09-30 | 2.32M shares 10-Q · filed 2019-11-07 | 2.05M shares derived: average of 2 quarters · filed 2019-11-07 | 1.99M shares 10-Q · filed 2019-11-07 | 1.50M shares derived: average of 4 quarters · filed 2020-02-26 |
| 2018-06-30 | 1.77M shares 10-Q · filed 2019-08-01 | 1.83M shares 10-Q · filed 2019-08-01 | 1.22M shares derived: average of 3 quarters · filed 2020-02-26 | 915.32K shares derived: average of 4 quarters · filed 2020-02-26 |
| 2018-03-31 | 1.89M shares 10-Q · filed 2019-05-03 | 944.31K shares derived: average of 2 quarters · filed 2020-02-26 | 629.54K shares derived: average of 3 quarters · filed 2020-02-26 | |
| 2017-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | 0.00 shares derived: average of 2 quarters · filed 2020-02-26 | 0.00 shares 10-K · filed 2020-02-26 | |
| 2017-09-30 | 0.00 shares 10-Q · filed 2018-11-07 | 0.00 shares 10-Q · filed 2018-11-07 | ||
| 2016-12-31 | 0.00 shares 10-K · filed 2019-02-19 | |||
| 2014-12-31 | 1.91M shares 10-K · filed 2017-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |